avasimibe has been researched along with cp 113818 in 2 studies
| Studies (avasimibe) | Trials (avasimibe) | Recent Studies (post-2010) (avasimibe) | Studies (cp 113818) | Trials (cp 113818) | Recent Studies (post-2010) (cp 113818) |
|---|---|---|---|---|---|
| 77 | 6 | 30 | 12 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barren, C; Berezovska, O; Bhattacharyya, R; Hutter-Paier, B; Huttunen, HJ; Kovacs, DM; Peach, C; Pettingell, W; Windisch, M | 1 |
| Barren, C; Duller, S; Frosch, MP; Havas, D; Hutter-Paier, B; Huttunen, HJ; Kovacs, DM; Peach, C; Windisch, M; Xia, W | 1 |
2 other study(ies) available for avasimibe and cp 113818
| Article | Year |
|---|---|
Inhibition of acyl-coenzyme A: cholesterol acyl transferase modulates amyloid precursor protein trafficking in the early secretory pathway.
Topics: Acetamides; Acetates; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; CHO Cells; Cricetinae; Cricetulus; Humans; Mice; Mice, Transgenic; Protein Transport; Pyridines; Secretory Pathway; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids | 2009 |
The acyl-coenzyme A: cholesterol acyltransferase inhibitor CI-1011 reverses diffuse brain amyloid pathology in aged amyloid precursor protein transgenic mice.
Topics: Acetamides; Acetates; Aging; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Apolipoproteins E; Brain; Cholesterol; Disease Models, Animal; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Gliosis; Humans; Image Processing, Computer-Assisted; Liver; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Peptide Fragments; Presenilin-1; Pyridines; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids | 2010 |